Cellectar Secures $617,500 New Financing Round

  • Feed Type
  • Date
    8/18/2014
  • Company Name
    Cellectar
  • Mailing Address
    3301 Agriculture Drive Madison, WI 53716 USA
  • Company Description
    Capitalizing on the unique characteristics of malignant cancer cells, Cellectar’s molecules are designed to find, treat and follow malignancies through the delivery of radiopharmaceuticals in a novel, highly selective way.
  • Website
    http://www.cellectar.com
  • Transaction Type
    Debt
  • Transaction Amount
    $617,500
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy